Cost Effectiveness of Intensive Lowering of Ldl Cholesterol with Pcsk9 Inhibitors as an Adjunct to High-Intensity Statin Therapy for Prevention of Major Vascular Events
May 1, 2016, 00:00
10.1016/j.jval.2016.03.118
https://www.valueinhealthjournal.com/article/S1098-3015(16)00186-8/fulltext
Title :
Cost Effectiveness of Intensive Lowering of Ldl Cholesterol with Pcsk9 Inhibitors as an Adjunct to High-Intensity Statin Therapy for Prevention of Major Vascular Events
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)00186-8&doi=10.1016/j.jval.2016.03.118
First page :
A48
Section Title :
Cardiovascular Disorders - Cost Studies
Open access? :
No
Section Order :
1449